Sun Pharmaceuticals Industries Ltd
NSE :SUNPHARMA BSE :524715 Sector : PharmaceuticalsBuy, Sell or Hold SUNPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
07 May 1515.35 (-0.90%) | 06 May 1529.15 (1.19%) | 03 May 1511.15 (-0.52%) | 02 May 1519.00 (1.13%) | 30 Apr 1502.10 (-1.28%) | 29 Apr 1521.60 (1.00%) | 26 Apr 1506.55 (-0.89%) | 25 Apr 1520.15 (2.32%) | 24 Apr 1485.75 (0.07%) | 23 Apr 1484.65 (-3.60%) | 22 Apr 1540.10 (1.14%) | 19 Apr 1522.80 (0.42%) | 18 Apr 1516.40 (-1.38%) | 16 Apr 1537.55 (-0.16%) | 15 Apr 1540.05 (0.00%) | 12 Apr 1540.00 (-3.99%) | 10 Apr 1604.05 (0.09%) | 09 Apr 1602.55 (0.18%) | 08 Apr 1599.70 (-0.58%) | 05 Apr 1609.00 (-0.64%) | 04 Apr 1619.35 (-0.03%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bullish
1514.79
10 DMA
Bullish
1509.08
20 DMA
Bearish
1535.17
50 DMA
Bearish
1562.43
100 DMA
Bullish
1458.12
200 DMA
Bullish
1301.75
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 07, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1568.69 | 1555.92 | 1524.44 | - | - |
R2 | 1555.92 | 1543.29 | 1521.41 | 1554.04 | - |
R1 | 1535.64 | 1535.5 | 1518.38 | 1531.88 | 1545.78 |
P | 1522.87 | 1522.87 | 1522.87 | 1520.99 | 1527.94 |
S1 | 1502.59 | 1510.24 | 1512.32 | 1498.83 | 1512.73 |
S2 | 1489.82 | 1502.45 | 1509.29 | 1487.94 | - |
S3 | 1469.54 | 1489.82 | 1506.26 | - | - |
Key Metrics
EPS
17.17
P/E
88.24
P/B
15.12
Dividend Yield
0.76%
Market Cap
3,63,583 Cr.
Face Value
1
Book Value
100.23
ROE
16.46%
EBITDA Growth
3,656.22 Cr.
Debt/Equity
0.08
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Sun Pharmaceuticals Industries Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 11414.85 | 11303.95 | 12145.28 | 12486.02 | 12630.9 |
PROFIT | 2166.01 | 2138.86 | 2284.5 | 2375.51 | 2583.5 |
EPS | 9 | 8.3 | 8.4 | 9.9 | 10.5 |
Sun Pharmaceuticals Industries Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 4713.78 | 6068.52 | 4629.61 | 5202.75 | 5150.55 |
PROFIT | 486.73 | 1916.97 | 526.31 | 888.63 | 788.32 |
EPS | 2 | -4.3 | 1.6 | 3.7 | 3 |
Profit & Loss (Figures in Rs. Crores)
Sun Pharmaceuticals Industries Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 16709.13 | 27825.18 | 29539.05 | 32473.22 | 27097.52 | 30524.51 | 33188.24 | 34995.53 | 39837.57 | 45081.01 | |
PROFIT | 4978.84 | 4581.78 | 5027.37 | 6932.28 | 2794.9 | 3661.85 | 3960.73 | 5728.26 | 6717.12 | 8604.93 | |
EPS | 18.47 | 25.79 | 23.51 | 32.66 | 10.7 | 13.38 | 17.45 | 9.52 | 14.2 | 35.68 |
Sun Pharmaceuticals Industries Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 3021.08 | 7921.92 | 8178.89 | 8366.9 | 9951.27 | 11825.95 | 13904.25 | 14487.76 | 16966.04 | 21379.36 | |
PROFIT | -59.51 | -1560.14 | -1349.86 | -266.99 | 1114.26 | 1865.28 | 3017.87 | 906.04 | -1337.5 | 3356.39 | |
EPS | 0 | 0 | 0 | 0 | 1.27 | 3.4 | 13.38 | 3.51 | -0.42 | 7.05 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | 207.12 | 207.12 |
Reserves Total | 55,755.45 | 47,771.29 | 46,222.85 | 45,024.52 | 41,169.13 | 38,074.18 | 36,399.74 | 32,741.15 | 25,382.59 | 18,317.83 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.67 | 48.38 | 0 |
Total Shareholders Funds | 55,995.38 | 48,011.22 | 46,462.78 | 45,264.45 | 41,409.06 | 38,314.11 | 36,639.67 | 32,982.48 | 25,638.09 | 18,524.95 |
Minority Interest | 3,320.09 | 3,054.89 | 3,017.05 | 3,860.24 | 3,313.54 | 3,884.16 | 3,790.86 | 4,085.25 | 2,851.19 | 1,921.18 |
Secured Loans | 0 | 0 | 7.83 | 257.49 | 109.47 | 114.35 | 780.45 | 284.23 | 339.99 | 74.94 |
Unsecured Loans | 6,885.87 | 1,290.3 | 3,860.75 | 8,057.39 | 10,404.89 | 10,270.92 | 9,051.32 | 8,212.53 | 8,656.12 | 2,485.92 |
Total Debt | 6,885.87 | 1,290.3 | 3,868.58 | 8,314.88 | 10,514.36 | 10,385.27 | 9,831.77 | 8,496.76 | 8,996.11 | 2,560.86 |
Other Liabilities | 929.52 | 1,019.64 | 1,098.63 | 1,334.28 | 1,004.7 | 462.71 | 1,341.82 | 2,105.51 | 2,718.68 | 2,610.76 |
Total Liabilities | 67,130.86 | 53,376.05 | 54,447.04 | 58,773.85 | 56,241.66 | 53,046.25 | 51,604.12 | 47,670 | 40,204.07 | 25,617.75 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 43,454.63 | 38,707.36 | 35,578.99 | 35,115.97 | 31,687.04 | 26,948.81 | 24,466.42 | 22,180.41 | 20,406.83 | 10,485.12 |
Less: Accumulated Depreciation | 19,034.51 | 16,042.2 | 14,026.01 | 12,269.06 | 9,850.5 | 8,096.16 | 6,791.25 | 6,308.16 | 7,724.36 | 3,667.84 |
Net Block | 24,420.12 | 22,665.16 | 21,552.98 | 22,846.91 | 21,836.54 | 18,852.65 | 17,675.17 | 15,872.25 | 12,682.47 | 6,817.28 |
Capital Work in Progress | 4,973.16 | 1,286.8 | 1,566.83 | 1,220.34 | 1,411.15 | 2,465.16 | 2,801.38 | 2,175.45 | 2,038.61 | 841.54 |
Investments | 14,830.09 | 12,848.59 | 9,612.45 | 10,143.11 | 7,902.53 | 7,142.87 | 1,191.88 | 1,829.88 | 2,716.3 | 2,786.02 |
Inventories | 10,513.05 | 8,925.13 | 8,997.02 | 7,874.99 | 7,885.98 | 6,880.69 | 6,832.81 | 6,422.54 | 5,667.99 | 3,123.01 |
Sundry Debtors | 11,438.51 | 10,484.59 | 9,061.4 | 9,421.24 | 8,884.2 | 7,815.28 | 7,202.61 | 6,775.66 | 5,106.13 | 2,200.42 |
Cash and Bank Balance | 5,770.29 | 5,033.35 | 6,445.51 | 6,487.55 | 7,275.6 | 9,929.38 | 15,140.84 | 13,181.65 | 10,998.04 | 7,590.15 |
Loans and Advances | 2,767.48 | 2,787.59 | 2,808.09 | 2,973.02 | 3,072.69 | 2,919.93 | 3,546.51 | 2,847.64 | 5,026.16 | 3,774.42 |
Total Current Assets | 30,489.33 | 27,230.66 | 27,312.02 | 26,756.8 | 27,118.47 | 27,545.28 | 32,722.77 | 29,227.49 | 26,798.32 | 16,688 |
Current Liabilities | 7,917.95 | 7,076.42 | 8,413.45 | 5,382.08 | 5,288.6 | 6,008.65 | 5,328.3 | 4,536.85 | 4,166.36 | 1,516.82 |
Provisions | 5,663.09 | 9,323.44 | 4,761.73 | 4,038.39 | 3,059.27 | 5,242.49 | 4,163.03 | 3,220.65 | 4,352.76 | 1,960.58 |
Total Current Liabilities & Provisions | 13,581.04 | 16,399.86 | 13,175.18 | 9,420.47 | 8,347.87 | 11,251.14 | 9,491.33 | 7,757.5 | 8,519.12 | 3,477.4 |
Net Current Assets | 16,908.29 | 10,830.8 | 14,136.84 | 17,336.33 | 18,770.6 | 16,294.14 | 23,231.44 | 21,469.99 | 18,279.2 | 13,210.6 |
Deferred Tax Assets | 5,409.36 | 4,431.17 | 4,712.19 | 4,141.5 | 3,441.01 | 3,095.5 | 2,994.37 | 3,560.31 | 2,245.84 | 1,199.97 |
Deferred Tax Liability | 2,276.81 | 1,613.45 | 1,200.26 | 1,024.35 | 990.42 | 907.13 | 816.34 | 514.09 | 494.2 | 288.95 |
Net Deferred Tax | 3,132.55 | 2,817.72 | 3,511.93 | 3,117.15 | 2,450.59 | 2,188.37 | 2,178.03 | 3,046.22 | 1,751.64 | 911.02 |
Other Assets | 2,866.65 | 2,926.98 | 4,066.01 | 4,110.01 | 3,870.25 | 6,103.06 | 4,526.22 | 3,276.21 | 2,735.85 | 1,051.29 |
Total Assets | 67,130.86 | 53,376.05 | 54,447.04 | 58,773.85 | 56,241.66 | 53,046.25 | 51,604.12 | 47,670 | 40,204.07 | 25,617.75 |
Contingent Liabilities | 4,361.77 | 3,773.19 | 4,714.13 | 5,075.52 | 5,290.4 | 7,430.51 | 7,345.51 | 4,162.26 | 3,538.68 | 1,646.13 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | 207.12 | 207.12 |
Reserves Total | 23,508.43 | 24,348.02 | 26,698.54 | 24,156.29 | 22,603.68 | 22,082.68 | 20,772.54 | 21,649.37 | 22,530.77 | 7,200.76 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.67 | 48.38 | 0 |
Total Shareholders Funds | 23,748.36 | 24,587.95 | 26,938.47 | 24,396.22 | 22,843.61 | 22,322.61 | 21,012.47 | 21,890.7 | 22,786.27 | 7,407.88 |
Secured Loans | 0 | 0 | 5.41 | 6.18 | 9.73 | 10.82 | 30.63 | 2,939.46 | 281.63 | 8.81 |
Unsecured Loans | 7,790.82 | 5,074.04 | 7,352.71 | 6,399.7 | 6,426.91 | 6,873.19 | 6,015.98 | 2,889.38 | 6,529.05 | 2,400.2 |
Total Debt | 7,790.82 | 5,074.04 | 7,358.12 | 6,405.88 | 6,436.64 | 6,884.01 | 6,046.61 | 5,828.84 | 6,810.68 | 2,409.01 |
Other Liabilities | 1,104.83 | 1,016.38 | 1,342.13 | 1,553.68 | 176.19 | 346.09 | 1,133.51 | 1,825.62 | 2,436.88 | 2,525.57 |
Total Liabilities | 32,644.01 | 30,678.37 | 35,638.72 | 32,355.78 | 29,456.44 | 29,552.71 | 28,192.59 | 29,545.16 | 32,033.83 | 12,342.46 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 17,744.68 | 17,194.98 | 15,812.29 | 8,244.71 | 7,461.34 | 6,572.66 | 4,988.08 | 4,103.7 | 5,995.07 | 1,973.53 |
Less : Accumulated Depreciation | 9,033.01 | 7,482.2 | 6,143.5 | 3,015.97 | 2,482.92 | 1,928.09 | 949.45 | 529.08 | 2,809.8 | 706.36 |
Net Block | 8,711.67 | 9,712.78 | 9,668.79 | 5,228.74 | 4,978.42 | 4,644.57 | 4,038.63 | 3,574.62 | 3,185.27 | 1,267.17 |
Capital Work in Progress | 852.91 | 828.64 | 1,090.38 | 596.61 | 642.54 | 987.84 | 1,100.5 | 767.73 | 1,090.59 | 480.46 |
Investments | 12,616.4 | 15,548.87 | 15,537.2 | 17,361.72 | 17,904.11 | 18,355.26 | 19,333.3 | 22,371.69 | 25,876.16 | 7,015.73 |
Inventories | 3,989.19 | 3,403.74 | 3,423.42 | 2,633.67 | 2,792.62 | 2,135.64 | 2,308.28 | 2,132.15 | 2,189.25 | 918.38 |
Sundry Debtors | 7,125.02 | 4,245.16 | 6,585.24 | 6,168.13 | 5,031.47 | 5,271.44 | 2,714.7 | 1,997.81 | 1,802.82 | 980.15 |
Cash and Bank Balance | 421.28 | 534.96 | 360.98 | 654.78 | 340.77 | 155.27 | 170.28 | 169.11 | 416.46 | 141.48 |
Loans and Advances | 4,708 | 1,326.85 | 2,329.44 | 2,089.47 | 2,756.96 | 1,968.1 | 1,154.92 | 943.63 | 947.82 | 2,799.43 |
Total Current Assets | 16,243.49 | 9,510.71 | 12,699.08 | 11,546.05 | 10,921.82 | 9,530.45 | 6,348.18 | 5,242.7 | 5,356.35 | 4,839.44 |
Current Liabilities | 7,533.98 | 7,524.56 | 6,891.41 | 4,956.61 | 5,713.96 | 4,586.35 | 3,829.25 | 3,541.69 | 3,345.03 | 1,141.07 |
Provisions | 809.5 | 2,562.55 | 1,204.66 | 1,097.94 | 2,543.73 | 2,652.75 | 1,847.43 | 1,179.61 | 2,066.69 | 688.03 |
Total Current Liabilities & Provisions | 8,343.48 | 10,087.11 | 8,096.07 | 6,054.55 | 8,257.69 | 7,239.1 | 5,676.68 | 4,721.3 | 5,411.72 | 1,829.1 |
Net Current Assets | 7,900.01 | -576.4 | 4,603.01 | 5,491.5 | 2,664.13 | 2,291.35 | 671.5 | 521.4 | -55.37 | 3,010.34 |
Deferred Tax Assets | 1,982.84 | 1,389.47 | 1,969.4 | 1,704.22 | 1,427.47 | 751.7 | 751.7 | 751.7 | 389.31 | 11.51 |
Deferred Tax Liability | 950.45 | 1,065.43 | 631.95 | 564.51 | 675.77 | 0 | 2.64 | 0 | 389.31 | 204.35 |
Net Deferred Tax | 1,032.39 | 324.04 | 1,337.45 | 1,139.71 | 751.7 | 751.7 | 749.06 | 751.7 | 0 | -192.84 |
Other Assets | 1,530.63 | 4,840.44 | 3,401.89 | 2,537.5 | 2,515.54 | 2,521.99 | 2,299.6 | 1,558.02 | 1,937.18 | 761.6 |
Total Assets | 32,644.01 | 30,678.37 | 35,638.72 | 32,355.78 | 29,456.44 | 29,552.71 | 28,192.59 | 29,545.16 | 32,033.83 | 12,342.46 |
Contingent Liabilities | 1,087.4 | 1,031.72 | 3,083.04 | 3,439.72 | 3,639.13 | 5,708.85 | 5,636.8 | 2,584.82 | 2,016.32 | 768.66 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 9,408.43 |
Depreciation | 2,529.43 |
Interest (Net) | -212.54 |
Dividend Received | 132.4 |
Prov. and W/O (Net) | 214.69 |
P/L in Forex | 336.81 |
Total Adjustments (PBT and Ext... | 2,722.56 |
Operating Profit before Workin... | 12,130.99 |
Trade and 0ther Receivables | -953.17 |
Inventories | -1,202.2 |
Trade Payables | 1,182.37 |
Total Adjustments (OP before W... | -5,661.82 |
Cash Generated from/(used in) ... | 6,469.17 |
Direct Taxes Paid | -1,509.84 |
Total Adjustments(Cash Generat... | -1,509.84 |
Cash Flow before Extraordinary... | 4,959.33 |
Net Cash from Operating Activi... | 4,959.33 |
Purchased of Fixed Assets | -2,085.58 |
Sale of Fixed Assets | 21.01 |
Purchase of Investments | -21,808.74 |
Sale of Investments | 20,896.84 |
Interest Received | 317.93 |
Investment in Group Cos. | -155.49 |
Acquisition of Companies | -4,685.82 |
Net Cash used in Investing Act... | -7,219.92 |
Proceed from 0ther Long Term B... | 8,159.78 |
Of the Long Tem Borrowings | -3,030.12 |
Of Financial Liabilities | -134.62 |
Dividend Paid | -2,519.73 |
Interest Paid | -99.24 |
Net Cash used in Financing Act... | 2,376.07 |
Net Profit before Tax and Extr... | 1,741.05 |
Depreciation | 1,600.87 |
Interest (Net) | 251.98 |
Prov. and W/O (Net) | 2,954.11 |
P/L in Forex | 34 |
Total Adjustments (PBT and Ext... | 4,823.4 |
Operating Profit before Workin... | 6,564.45 |
Trade and 0ther Receivables | -2,932.01 |
Inventories | -585.45 |
Trade Payables | 406.36 |
Total Adjustments (OP before W... | -5,625.38 |
Cash Generated from/(used in) ... | 939.07 |
Direct Taxes Paid | -431.99 |
Total Adjustments(Cash Generat... | -431.99 |
Cash Flow before Extraordinary... | 507.08 |
Net Cash from Operating Activi... | 507.08 |
Purchased of Fixed Assets | -962.43 |
Sale of Fixed Assets | 8.3 |
Purchase of Investments | -3,692.95 |
Sale of Investments | 3,695.25 |
Interest Received | 152.23 |
Cancellation of Investment in ... | 6 |
Acquisition of Companies | -15.92 |
Net Cash used in Investing Act... | -685.64 |
Proceed from 0ther Long Term B... | 8,216.92 |
Of the Long Tem Borrowings | -5,492.96 |
Of Financial Liabilities | -34.81 |
Dividend Paid | -2,518.88 |
Interest Paid | -0.96 |
Net Cash used in Financing Act... | 169.31 |
Company Details
Registered Office |
|
Address | Sun Pharma Advanced Res.Centre, Tandalja |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-6615500 |
Fax. No. | 91-265-2354897 |
secretarial@sunpharma.com | |
Internet | http://www.sunpharma.com |
Registrars |
|
Address | Sun Pharma Advanced Res.Centre |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-6615500 |
Fax. No. | 91-265-2354897 |
secretarial@sunpharma.com | |
Internet | http://www.sunpharma.com |
Management |
|
Name | Designation |
Dilip S Shanghvi | Managing Director |
Sudhir V Valia | Non-Exec & Non-Independent Dir |
Sailesh T Desai | Whole-time Director |
Gautam Doshi | Non-Exec. & Independent Dir. |
Pawan Goenka | Lead Independent Director |
Rama Bijapurkar | Independent Director |
Anoop Deshpande | Company Sec. & Compli. Officer |
Sanjay K Asher | Independent Director |
Rolf Hoffmann | Independent Director |
Aalok Shanghvi | Whole Time Director |